Clinical Trial: A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06939595) titled 'A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer' on April 21.

Brief Summary: The goal of this Phase 3 clinical trial is to compare efficacy and safety of CT-P51 and European Union (EU) approved Keytruda in combination with platinum pemetrexed chemotherapy in patients with previously untreated metastatic nsNSCLC.

Study Start Date: Jan. 30

Study Type: INTERVENTIONAL

Condition: Non Squamous Non Small Cell Lung Cancer

Intervention: DRUG: CT-P51

CT-P51 200mg with pemetrexed and cisplatin or carboplatin will be administered every 3 weeks for a maximum of 4 c...